Featured

Bio-Electronic Market Competitor Analysis Report Covering Abbott, Beckman Coulter, Life Sensors

This report studies the global Bio-Electronic market, analyzes and researches the Bio-Electronic development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

Bioelectronics Corporation

Avago

Honeywell International

Danaher Corporations

Omnivision Technologies

Sensirion

Medtronics

BodyMedia

Sotera Wireless

Siemens

Roche

Universal Biosensors

Abbott

Beckman Coulter

Life Sensors

 

Browse Complete Report @ https://www.reportsmonitor.com/global-bio-electronic-market-size-status-and-forecast-2022

 

Market segment by Regions/Countries, this report covers

United States

EU

Japan

China

India

Southeast Asia

 

Request Sample Copy @ https://www.reportsmonitor.com/request-sample/?post=139733

 

Market segment by Type, Bio-Electronic can be split into

Bio-Electronic Technology

Bio-Electronic Devices

Bio-Electronic Medicine

 

To enquire about this report visit https://www.reportsmonitor.com/make-enquiry/?post=139733

 

Market segment by Application, Bio-Electronic can be split into

Disease Prevention

Disease Diagnose and Treatment

Prosthetics and therapeutics

Biomedical Research

 

Browse Similar Semiconductor and Electronics Industry Reports

 

 

About Reports Monitor

Reports Monitor is a platform for companies looking to meet their market research and business intelligence requirements. Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics driven intelligence. We have a vast collection of reports, covering maximum industries worldwide. Our process is meticulously planned and executed in order to use maximum resources and explore the market for getting genuine insights. The prime focus is to get reliable data, Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis.

 

Contact Us

Jay Mathews

Direct: +1 513 549-5911

Email: sales@reportsmonitor.com

Website: http://www.reportsmonitor.com

 

Follow Us

LinkedIn: https://www.linkedin.com/company/reports-monitor

Facebook: https://www.facebook.com/ReportsMonitor

Twitter: https://twitter.com/reportsmonitor

Google Plus: https://plus.google.com/u/0/104187516885663390925

Youtube: https://www.youtube.com/channel/UCW8_Fb1CyDrHQumP5LmyW1A

Blogger: https://reportsmonitor.blogspot.com

WordPress: https://reportsmonitor.wordpress.com

Advertisements

Liquid Biopsy Market Size, Industry Analysis & Forecast Report by 2025

Global Liquid Biopsy Market Analysis and Industry Outlook

The global liquid biopsy market accounted for $ 1,574 million in 2017 and is projected to reach $ 11,524 million by 2025. North America was the highest contributor to the liquid biopsy market due to the presence of leading bio-tech companies and highly equipped research facilities. Asia-Pacific is anticipated to witness highest growth rate in the analysis period owing to rapid adoption and growth in awareness regarding non-invasive liquid biopsy test.

Liquid biopsies provide valuable insight regarding the presence of tumor DNA and fragments in the patient by testing patients’ blood sample.  These tests can provide efficient disease monitoring as well as early detection of various types of cancer which can allow health-care providers to eradicate or neutralize the disease before it can become life-threatening

Get a Free Sample Copy @ https://goo.gl/QyxgJA

Prevalence of cancer and surge in the incidence of various types of cancer are expected to drive the liquid biopsy market. In addition, advantages of liquid biopsy over solid tissue biopsy techniques are one of the major drivers of this market. However, unfavorable reimbursement scenario in many countries and alternatives to liquid biopsy can impede market growth.

By-product and services, the assay segment is expected to lead the liquid biopsy market due to growth in liquid biopsy test in many developed regions. Lung cancer is likely to dominate the cancer type segment owing to the global prevalence of lung cancer.

In 2017, North America dominated the liquid biopsy market due to the presence of modern health-care infrastructure and well equipped research facilities in the countries such as U.S. and Canada. However, Asia-Pacific is likely to have the highest growth rate in the market owing to huge patient population pool and rapid adoption of modern health-care techniques.

View Full Report @ https://goo.gl/dqDDPn

Global Liquid Biopsy Market Key Findings

Hospital & laboratory accounted for the highest revenue in the analysis period. In Asia-Pacific region, China is projected to grow at the highest CAGR. The instruments segment is expected to grow at the highest rate in the product and services segment. Government & academic research center segment is expected to develop at the highest rate during the study period.

About Us

Reports Monitor is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries including Healthcare, Technology, Chemicals, Materials, and Energy. With an intrinsic understanding of many business environments, Reports Monitor provides strategic objective insights.

Contact Details

Email: sales@reportsmonitor.com

Phone: +1 513 549 5911

Machine Learning Market Demand, Growth, Opportunities and Key Player Forecast to 2025

Machine Learning Market Overview

Machine learning solutions facilitate machines to learn without being specifically programmed for it. Machine learning algorithms can be used to perform tasks such as statistical arbitrage, image recognition, medical diagnoses, speech recognition, classification, learning association, prediction and information extraction. Some of the real-life applications of machine learning are security, fraud detection, reconditions and financial trading.

Technological advancement in machine learning is one of the key drivers for machine learning market. Modern machine learning solutions are more reliable than their older counterparts. Advanced processors are able to handle a large amount of data in short period of time allowing machine learning solutions to work smoothly.

Get a Free Sample Report @ https://goo.gl/EjZTJY

Big players in the industry are investing heavily in machine learning research and development. Numbers of machine learning start-ups are also contributing to the growth of the global machine learning market.

The U.S hold a significant share of global machine learning market in 2016 in terms of revenue generated. Numbers of prominent machine learning players are based in the U.S. The U.S. market is expected to grow at significant CAGR over the forecast period from 2017 to 2025. Asian machine learning market is expected to overtake the North American machine learning market by the end of the forecast period.

Multiple machine learning giants are using machine learning technologies to optimize their revenue through multiple revenue sources. For example, multiple machine learning players are using machine learning to optimize online advertising or product recommendations. Companies with the large in-house database, such as search engine giants or E-commerce giants are at an advantage while investing in machine learning research and development. They can apply advanced machine learning tools to make efficient use of available in-house data to increase revenue from other sources and at the same time can focus on new machine learning based product development.

Implementation challenges are the key restrain for global machine learning market. Machine learning solutions are difficult to implement in real life and need to undergo extensive testing before implementation in the real world situations.

Machine learning are transforming business processes in multiple industries. In manufacturing industry machine learning can be used to increased production capacity or to reduce material costs by providing relevant financial, operational and supply chain data. Manufacturing industry is expected to hold significant market share of global machine learning market in terms of revenue generated in 2016. Health-care and BFSI industries also contributed to the significant amount of revenue in 2016.

Small and medium-sized enterprises are increasingly adapting to the changing market scenario by using machine learning in business processes. Machine learning revenue from SME’s is expected to grow at significant CAGR over the forecast period.

Managed services accounted for significant amount of revenue share in 2016. Professional services are expected to grow at significant CAGR over the forecast period.

View Full Report @ https://goo.gl/WemcKg

In Europe Germany holds the highest revenue share for global machine learning market and is also expected to grow at significant CAGR over the forecast period. Asia Pacific machine learning market is expected to grow at highest CAGR over the forecast period. In Asia Pacific china holds the highest market share in terms of revenue followed by Japan. In Latin America Middle East and Africa (LAMEA) segment Brazil accounted for significant amount of market share in terms of revenue for the machine learning market in 2016.

About Us

Reports Monitor is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries including Healthcare, Technology, Chemicals, Materials, and Energy. With an intrinsic understanding of many business environments, Reports Monitor provides strategic objective insights.

Contact Details

Email: sales@reportsmonitor.com

Phone: +1 513 549 5911

Healthcare Blockchain Technology Market Trend Analysis and Industry Research Report 2018

The blockchain is essentially a distributed database of records or public ledger of all transactions or digital events that have been executed and shared among participating parties. The blockchain contains a certain and verifiable record of every single transaction ever made. During last few years there is an significant increase in the blockchain technology market. The global blockchain market is majorly driven by increasing adoption of the blockchain technology and increasing need for the fast transaction. Additionally, increasing healthcare spending and incorporation of IT in healthcare in the sector have fueled the market growth. The global blockchain technology in healthcare is expected to grow at a CAGR of 46.84% during the forecast period.

Get free sample report @ https://goo.gl/pz3zNn

The global healthcare blockchain technology market is segmented on the basis of types and application.On the basis of types, the Healthcare blockchain technology market is segmented into private, public, and others. On the basis of application, the market is segmented into payments & transactions, electronic health records, smart contracts, precision medicine, others.

America commands the largest share in the Healthcare blockchain technology market owing to the increasing adoption and awareness about of the blockchain technology. North America holds the major share in Americas market. Europe holds the second leading position due to the presence of strong government support and huge healthcare spending. The Asia Pacific is expressing the fastest growth for the market due to the presence of huge opportunities and the presence of fastest growing economy. On the other hand, due to lack of awareness about the technology, and presence of poor economy in Africa region the Middle East & Africa holds the least share in the Healthcare blockchain technology market.

The key players in the market are: IBM Corporation (U.S.), Accenture (Ireland), Microsoft (U.S.), Capgemini (France), Deloitte Touche Tohmatsu Limited (U.K), Blockchain Tech Ltd (U.K), Digital Asset Holdings (U.S.), Global Arena Holding, Inc. (U.S.), Ethereum (U.S.), BitFury Usa Inc. (U.S.), Chain, Inc. (U.S.), Coinbase Inc. (U.S.), Abra, Inc. (U.S.).

For instance, in December 2017, Acana Capital Corp., has completed its acquisition of Blockchain Technology Group Inc.

View full report @ https://goo.gl/kWZzGf

Key Findings:

America holds the leading share of 41.64% in the global healthcare blockchain technology market. Public type of blockchain technology holds the share of more than half of the market by types. On the basis of applications, payments & transactions will lead the market during the forecast period.

Global healthcare blockchain technology market-

By types: private, public, and others.

By application: payments & transactions, electronic health records, smart contracts, precision medicine, and others.

By region: America, Europe, Asia Pacific, and The Middle East & Africa.

 

About Us

Reports Monitor is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries including Healthcare, Technology, Chemicals, Materials, and Energy. With an intrinsic understanding of many business environments, Reports Monitor provides strategic objective insights.

Contact Details

Email: sales@reportsmonitor.com

Phone: +1 513 549 5911

Personalized Medicines Market to Grow Rapidly in near Future

During last decade, pharmacogenomics has gained a huge attention in the treatment of the diseases such as cancer, diabetes, genetic diseases and others. Personalized medicines are manufactured according to the safety requirement of the patient or group of patients. The global personalized medicines market is majorly driven by increasing prevalence of cancer, and other chronic diseases, rapid development in the healthcare sector and increasing need for the better treatment options. Moreover, rising healthcare expenditure, and strong government support for research & development have fuelled the Personalized medicines market growth. However, long approval time, and high cost of manufacturing may slow the growth of the Personalized medicines market.

Get Access to Sample Pages @ https://goo.gl/w1As7U

The global personalized medicines market is expected to grow at a CAGR of 10.3% during the forecast period.

The global personalized medicines market is segmented on the basis of products, applications and end users.

On the basis of products, the market is segmented into personalized nutrition & wellness, personalized medical care, personalized diagnostic, personalized therapeutic. Personalized nutrition & wellness are further segmented into nutrition care, alternative medicines care, medical retail, and others. Personalized medical care is sub-segmented into telemedicine & remote patient monitoring, EMR, and other.

On the basis of application, the Personalized medicines market is segmented into disease treatment, biomarker identification, clinical research, and others. Disease treatment segment is further segmented into oncology, psychiatry, infectious diseases, cardiology, endocrinology, neurology, gastroenterology, rheumatology, and others.

On the basis of end users, the Personalized medicines market is segmented into hospitals & clinics, diagnostic laboratories and testing facilities, research laboratories & academic institutes, and others.

America commands the largest share in the Personalized medicines market owing to the huge patient population, and increasing demand for the better diagnostic and therapeutic treatments. Americas holds nearly half of the market share whereas the Middle East & Africa holds least. Asia Pacific region shows the fastest growth for the market owing to presence of huge opportunities for the market development and increasing healthcare expenditure.

The key players in the Personalized medicines market are: Siemens Healthcare GmbH (Germany), Quest Diagnostics (U.S.), Sanofi (France), Pfizer Inc. (U.S.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN (Germany), CELERA (U.S.), Amgen (U.S.), and 23andme (U.S.)

Segmentation Covered

By Products – Personalized Nutrition & Wellness, Nutrition Care, Alternative medicines care, Medical Retail, Others, Personalized Medical Care, Telemedicine & Remote Patient Monitoring, EMR, Other, Personalized Diagnostic, Personalized Therapeutic

By Applications – Disease Treatment, Oncology, Lung Cancer, Breast Cancer, Prostate Cancer, Others, Psychiatry, Infectious Diseases, HIV, Hepatitis B, Others, Cardiology, Endocrinology, Neurology, Gastroentrology, Rheumatology, Others, Biomarker Identification, Clinical Research, Others

By End Users – Hospitals & clinics, Diagnostic laboratories and testing facilities, Research Laboratories & Academic institutes, Others

View Full Report @ https://goo.gl/wVVZrq

We periodically update our market research studies to ensure our clients get the most recent, relevant, and valuable information. Reports Monitor has a strong base of analysts and consultants from assorted areas of expertise. Our industry experience and ability to zero-in on the crux of any challenge gives you and your organization the ability to secure a competitive advantage.

About Us

Reports Monitor is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries including Healthcare, Technology, Chemicals, Materials, and Energy. With an intrinsic understanding of many business environments, Reports Monitor provides strategic objective insights.

Contact Details

Email: sales@reportsmonitor.com

Phone: +1 513 549 5911

Artificial Intelligence in Health-care Market – Global Marketing Analysis and Industry Research Report

Artificial Intelligence in Health-care Market

AI in health signifies a collection of several technologies enabling machines to sense, act, learn and comprehend so they can perform clinical health-care and administrative functions. AI is primarily likely to be adopted as an assistance system, rather than replacement, for physicians. It will supplement physicians’ diagnoses, at the same time will also provide appreciated insights for the AI to improve and learn continuously. For improving health-care, AI in medicine is a great idea which can advance the health-care professional and patient communication. AI is poised to bend through major sectors or industry of the economy over the next decade, no industry should be more hospitable to the technology than that of healthcare. The US being the most technologically progressive nation in the globe and one with the most exclusive health-care industry, the country is expected to be the proving ground for AI-powered medicine.

Get a Free Sample Report @ https://www.reportsmonitor.com/request-sample/?post=581168

Factors such as fast and accurate diagnostics, reduce cost, virtual presence in the form of tele-medicine in remote areas and reduce human errors are some of the major reasons driving the Artificial Intelligence market growth. It would be essential to address concerns over the security, protection, and privacy of delicate health data. The intricacy of human biology and the necessity for further technological improvement also mean that some of the more innovative applications will take time to reach their potential customers and gain acceptance from regulators, health-care providers and patients. The balanced patient to health-care professional ratio on account of the AI united with its rising incorporation with existing systems is expected to present the Artificial Intelligence market with several great opportunities.

In the US, the FDA has regulatory authority over medical devices and AI technologies. FDA has issued a number of assistance documents to support in identifying when mobiles apps and software are considered to be medical devices. Further important deliberations, given the ability of AI to capture different forms of personal data, are cyber-security and data protection, which are expected to become very important to safeguard the sustainability of the AI system and technology. In the EU, these guidelines are soon to be renovated by General Data Protection Regulation (GDPR). APAC has been the fastest developing region in terms of innovations and growth owing to the presence of the chief companies such as Microsoft, IBM, Google, Apple, GE Health-care, and Siemens among others. China is the fastest growing country in the artificial intelligence in the health-care market and is expected to overtake the US in term of AI technology in coming future.

Have a query on this report? Get in touch with analysts @ https://www.reportsmonitor.com/make-enquiry/?post=581168

 

Artificial Intelligence in Healthcare Market Segmentation

By Technology

  • Deep Learning
  • Querying Method
  • Natural Language Processing (NLP)
  • Context Aware Processing

By Application

  • Drug Discovery
  • Medical Imaging and Diagnosis
  • Virtual Assistant
  • In Patient Care and Hospital Management
  • Others

By Geography

  • North America
    • US
    • Canada
    • Rest Of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA

View Full Report @ https://www.reportsmonitor.com/global-artificial-intelligence-in-health-care-market-by-technology-deep-learning-querying-method-natural-language-processing-and-context-aware-processing-by-application-drug-discovery-medi/

About Us

Reports Monitor is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries including Healthcare, Technology, Chemicals, Materials, and Energy. With an intrinsic understanding of many business environments, Reports Monitor provides strategic objective insights.

We periodically update our market research studies to ensure our clients get the most recent, relevant, and valuable information. Reports Monitor has a strong base of analysts and consultants from assorted areas of expertise. Our industry experience and ability to zero-in on the crux of any challenge gives you and your organization the ability to secure a competitive advantage.

Contact Details

Email: sales@reportsmonitor.com

Phone: +1 513 549 5911

Biosimilar Market By Recombinant Products, By Application, Opportunities and Forecast 2017-2025

The ” Global Biosimilar market, By Recombinant Products (Non-Glycosylated Proteins, Glycosylated Proteins, peptides and others) By Application (Oncology, Blood Disorders, Chronic and Auto-immune Disease, infectious diseases and others) opportunities and forecast 2017-2025″ report has been added to Reports Monitor’s database.

The study for Biosimilar Market will provide market size, estimates and forecast based on the following years:

Historic data: 2015

Base Year Estimate: 2016

Forecast: 2017 to 2025

Biosimilars are the copied version of biologics that have undergone patent expiration. The major factors that are driving the growth of the market includes  increasing demand for these drugs due to rising geriatric population, their cost-effectiveness, strategic collaborations ensuring enhanced throughput and clinical trial activities for these drugs, and increasing support from the government  and initiatives to develop and promote these drugs.

Get a Free Sample of this Report @ https://www.reportsmonitor.com/request-sample/?post=581161

Europe has around 27 biosimilar drugs available, US has been slower to hold on this trend. Recently, the growth is accelerating due to patent expiration of popular biologics. Also, it is expected that the rising acceptance of these drugs by governments and physicians, and the growth of real-world evidence will help build patient confidence and trust with regards to the efficacy and safety of these products. This, in turn will drive growth in the market. Furthermore, as the price of these drugs is 30 to 50 per cent lower than the originals, there exist huge potential healthcare cost savings, which will also drive the market for these copied drugs. Currently, there are more of these drugs in progress across the Asia-Pacific than anywhere else, leading to numerous great opportunities. Producers of these drugs in Asian countries share various benefits over their competitors in US and EU markets.

Have a query on this Report? Speak to Analyst @ https://www.reportsmonitor.com/make-enquiry/?post=581161

Over the next three to four years, it will be significantly easier to obtain sanction for these drugs development in the U.S. The faster drug makers can get these drugs through the governing agencies, and as the cost of developing these drugs decreases, the greater the chances will be for more firms to step in and create impact on the industry. With more players producing these drugs, there will be more options which mean a bigger number of people will be able to obtain the benefits, these drugs provide. Also, it is expected that the market won’t be able to withstand the large number of participants in the long term, hence it is expected that only the most successful businesses sustaining a presence. Companies like Teva and Coherus, Sandoz are anticipated to show a great deal of progress over the next decade as they bring more of these products to market. This is the market that will continue to be in focus in this billion-dollar business industry with the probability of changing the industry forever.

To be successful in the sector, companies must implement the quality and latest technology initiatives, such as design of experiments, quality by design, and process analytical technology. They also take a practical approach in risk mitigation by accumulating risk management plans and accepting production best practices that are outlined by regulatory agencies and industry associations.

For more information on this report visit https://www.reportsmonitor.com/biosimilars-market-size-share-industry-forecast-by-product-type-application-2017-2025/

 

Contact Details

Email: sales@reportsmonitor.com

Phone: +1 513 549 5911

Biosimulation Market Assessment and Industry Size Analysis Report 2017

ReportsMonitor.com has published Global Biosimulation Market – Industry Size Analysis and Forecast, by Product & Application.

The global biosimulation market is expected to grow from USD 1,467.7 million in 2016 to USD 3,897.0 million by 2024. The high growth is anticipated in this market due to growing awareness about the benefits of using predictive technology platforms, rise in collaboration between scientific researchers and technology companies, growing economic burden of disease and rising R&D expenditures. The development of new data bases capturing data points which were earlier not available have significantly improved the quality of research and data accuracy. The current and future development of drugs and medical products is expected to be highly dependent on the simulation/predictive analytic systems and therefore the market participants are significantly establishing high end data processing and analytics teams across the globe.

Download Free Sample Report @ https://www.reportsmonitor.com/request-sample/?post=457668

The global healthcare expenditure is witnessing rapid growth due to various factors such as rise in prevalence of chronic diseases, aging population, increasing cost of healthcare operations, high investment in R&D, and several other factors. In addition, the changing healthcare landscape with the introduction of advanced therapies, devices, and declining Medicare budgets is forcing the healthcare providers to utilize automation and improve the efficiency in providing healthcare.

The developed economies and the emerging economies have a wide disparity in the healthcare spending as a percentage of GDP and the out of pocket healthcare expenditure. The regions such as the U.S., UK, and other western economies have a robust healthcare system with proper reimbursement mechanism, streamlined drug approval process and continuous investment in research and development.

View Full Report @ https://www.reportsmonitor.com/global-biosimulation-market-industry-size-analysis-and-forecast-by-product-application/

Therefore, it is imperative for the healthcare industry to utilize artificial intelligence for process automation, R&D simulation, product toxicology studies and several other applications. The use of biosimulation software’s is witnessing rapid growth in the developed regions such as U.S., UK, Germany and other countries with high R&D expenditure. The ability to predict or simulate a particular condition or several scenarios in real time, is significantly improving the research outcomes. The benefits of using high tech software’s in the R&D management and operations management have been adequately established by several researchers and scientists. Moreover, the pharmaceutical companies, which contribute to the bulk of the revenue, are highly appreciative of the improvement in access to databases with analytical features. The target market or end user base of pharmaceuticals, clinical research organizations (CRO’s) and others are witnessing an era of terabyte data sets for each clinical indication, and using these softwares, the various factors such as the risk to the patient, and therapeutic indications, can be easily identified in a short span of time. Moreover, the future of new drug development is largely going to be based on these simulation software’s with advanced learning and automation capabilities.

Enquire About this Report @ https://www.reportsmonitor.com/make-enquiry/?post=457668

The global biosimulation market has been segmented on the basis of product, application, end-use and by region. Based on product, the market is classified as software and services. The services category is further split as in-house services and contract services. The market segmenation by application includes drug development, drug discovery and others. The categorization based on end-use includes pharma &biotech industry, CRO’S, academic institutes and regulatory authorities.

The biosimulation market by geography includes separate analysis of five major regions with top revenue contributing nations. Based on geography, the market is split into North America, Europe, Asia Pacific, Latin America and Middle East.

 

Download Free Sample Copy

 

Some Points from Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Biosimulation Market Overview

Chapter 4 Biosimulation Industry Outlook

Chapter 5 Global Biosimulation Market by Product

Chapter 6 Biosimulation Market by Application

Chapter 7 Biosimulation Market by End-Use

Chapter 8 Biosimulation Market Regional Outlook

Chapter 9 Competitive Landscape